Vale (NYSE:VALE) has outperformed the market over the past 20 years by 1.67% on an annualized basis producing an average annual return of 9.39%. Currently, Vale has a market capitalization of $60.30 billion.
Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
Today Angi Inc. (NASDAQ:ANGI) a leading and comprehensive solution for all home needs, announced the appointment of Joey Levin, CEO of IAC and Chairman of Angi, to CEO of Angi. Oisin Hanrahan has stepped down as CEO and